US equities |
TSLA $393.62 ▲+5.75% MU $887.75 ▲+1.16% SPCX $146.49 ▼-0.68% NVDA $214.55 ▲+1.70% META $636.31 ▼-0.98% AAPL $344.74 ▼-0.86% SNDK $1,244.47 ▲+0.52% AMZN $250.35 ▲+0.95%
FinancialContent

Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.105 +0.025 (+0.81%)
Delayed Quote Updated: 10:16 AM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
22 23 Next >
News headline image
The Latest Analyst Ratings for Ardelyx ↗
 
Via Benzinga
News headline image
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
7 Penny Stocks You’ll Regret Not Buying Soon: November 2023 ↗
Unlock robust upside potential by wagering on these top penny stocks to buy in a volatile market at this time. 
Via InvestorPlace
News headline image
Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Why Ardelyx Stock Soared Today ↗
Ardelyx delivered a strong quarter thanks to solid demand for its first FDA-approved product. Here's what investors need to know. 
Via The Motley Fool
News headline image
XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Departure of Board Member
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Participate at the Jefferies London Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
5 OTC Stocks With The Potential To Explode In 2024 ↗
Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms. 
Via Benzinga
News headline image
Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
3 Penny Stocks to Buy and Hold for the Next 10 Years ↗
These three penny stocks are the ones to buy and hold through the market conditions and the years to come for returns. 
Via InvestorPlace
News headline image
Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Why Ardelyx Stock Popped Today ↗
Ardelyx finally received the long-awaited FDA approval for its chronic kidney disease drug. 
Via The Motley Fool
News headline image
Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023
Conference call scheduled for 8:00 a.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Crude Oil Rises Sharply; Ardelyx Shares Spike Higher ↗
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling more than 1% on Wednesday. The Dow traded down 0.70% to 33,760.26 while the NASDAQ fell 1.45% to 13,338.71. The S&P 500 also... 
Via Benzinga
Topics Stocks
News headline image
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection. 
Via Benzinga
Topics Bankruptcy
News headline image
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Ardelyx Inc. (NASDAQ: ARDX) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
News headline image
Workhorse (WKHS) Stock Jumps on Drone Business Success ↗
Workhorse stock is getting a boost on Wednesday morning after providing WKHS investors with an update on its drone business. 
Via InvestorPlace
News headline image
FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug ↗
ARDX stock is rallying after the U.S. Food and Drug Administration (FDA) approved Ardelyx's kidney disease treatment. 
Via InvestorPlace
News headline image
After Initial Rejection, FDA Approves Ardelyx's Kidney Disease-Related Drug ↗
The FDA approved Ardelyx Inc's (NASDAQ: ARDX) Xphozah (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on... 
Via Benzinga
News headline image
Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital
Additional non-dilutive capital extends runway to support the launch of XPHOZAH® (tenapanor) and continued commercial investment into IBSRELA® (tenapanor) in the U.S. 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday! 
Via InvestorPlace
News headline image
Ardelyx to Present Data Updates for XPHOZAH (tenapanor) for Hyperphosphatemia at Kidney Week 2023 November 1-5 in Philadelphia, PA
From Ardelyx, Inc.
Via GlobeNewswire
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
22 23 Next >